Thoma Jeanne

SEC Form 4 insider trading activity

Thoma Jeanne has filed 2 SEC Form 4 filings (2 transaction rows) across 1 company, with disclosures dating back to 2026. 2 of those filings fall inside the rolling window. Most recent filing: Sep 15, 2026.

On the most recent filing, Thoma Jeanne is listed as Director at ANI PHARMACEUTICALS INC. Inside the rolling window, Thoma Jeanne reported no open-market purchases and 1 open-market sale totaling $72K in ANIP.

Companies traded

Other insiders at ANIP

Insider Buying

$0

reported purchases (SEC code P)

Insider Selling

$72K

reported sales (SEC code S)

Companies

1

in the rolling window

Source
ANIP
Thoma Jeanne
Sale$72KSep 15SEC ↗
Showing 1–1 of 1
1 / 1

Frequently asked questions

How many SEC Form 4 filings has Thoma Jeanne made?

Thoma Jeanne has filed 2 SEC Form 4 filings (2 transaction rows) across 1 company since 2026.

Which companies does Thoma Jeanne trade?

Thoma Jeanne has filed SEC Form 4 disclosures for 1 company, including ANIP.

When was Thoma Jeanne's most recent SEC Form 4 filing?

Thoma Jeanne's most recent SEC Form 4 filing on Tracefour is dated Sep 15, 2026.

What is Thoma Jeanne's total buy and sell value in the current window?

Inside the rolling retention window, Thoma Jeanne bought $0 and sold $72K based on SEC Form 4 filings.

What was Thoma Jeanne's largest disclosed transaction?

The largest disclosed transaction in the current window is a sale of 1,000 ANIP shares on 2026-09-11, worth $72K, per SEC Form 4 filings.